Abstract
Immunodiagnostic assays are procedures that utilize products of the immune response as integral parts of the test. Basically, immunodiagnostic assays use antibodies generated either against a single antigen or antigens associated with a specific analyte, pathogen, or disease condition. Historically, polyclonal antibodies generated against antigens of interest were produced in small animals, such as mice, rats, rabbits, and goats, by injecting the antigen preparation with an adjuvant (such as Freund’s complete or incomplete adjuvant), according to a schedule previously determined to give a maximum immune response. The test animals typically respond to the antigen preparation by producing antibodies to every recognizable antigenic epitope, thus inducting a polyclonal immunoglobulin response. Immunoglobulins are composed of two sets of identical amino acid chains; two heavy chains and two shorter light chains. Heavy chains are connected to each other by two or more disulfide bonds, whereas each light chain is connected to a heavy chain by one disulfide bond. The amino (N) terminus of a light and heavy chain compose the hypervariable amino acid region, or the “Fab” portion of the antibody molecule, whereas the carboxylic acid (COOH) terminus of both heavy chains compose the crystallizable, or Fc portion of the antibody (see Fig.17.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Pertinent Reading
Articles
Bakerman, S. 1980. Enzyme immunoassays.Lab. Management(August) pp. 21–29.
Better, M. and A.H. Horwitz. 1989. Expression of engineered antibodies and antibody fragments in microorganisms.Methods Enzymol.178:476–496.
Beutner, E.H., S. Krasny, V. Kumar, R. Taylor, and T.P. Chorzelski. 1983. Prospects and problems in the definition and standardization of immunofluorescence. in:Defined Immunofluorescence and Related Cytochemical Methods.(Eds., E.H. Beutner, R.J. Nisengard, and B. Albini) Annals of the New York Academy of Sciences, vol. 420, pp. 28–54.
Bidart, J.M., M. Ozturk, and D.H. Bellet. 1985. Identification of epitopes associated with hCG and the ß-hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.J. Immunol.134:457–464.
Carter, J.H. 1984. Enzyme immunoassays: Practical aspects of their methodology.J. Clin. Immunoassay7:64–72.
Coons, A.H., H.J. Creech, R.N. Jones, and E. Berliner. 1942. The demonstration of pneumococcal antigens in tissues by the use of fluorescent antibody.J. Immunol.45:159–170.
Coulis, P.A., J.J.G. Wang, E.P. Kang, W. Present, and C.Y. Wang. 1987. Peptide-based immunodiagnosis of retroviral infections.ACPRNovember, pp. 34–43.
Drysdale, J.W. 1983. Ferritin as a tumor marker.J. Clin. Immunoassay6:234–240.
Engvall, E. and P. Perlmann. 1971. Enzyme linked immunosorbent assay ELISA: Quantitative assay for IgG.Immunochemistry8:871–874.
Hosoda, H., W. Takasaki, T. 0e, R. Tsukamoto, and T. Nambara. 1986. A comparison of chromogenic substrates for horseradish peroxidase as label in steroid enzyme immunoassay.Chem. Pharm. Bull.34:4177–4180.
Hubbard, R. 1983. Monoclonal antibodies: production, properties and applications. in:Topics in Enzyme Fermentation Technology(vol.7).(Ed., A. Wiseman) Ellis Horwood, Chichester, UK, pp. 196–263.
Kohler, G. and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity.Nature256:495–497.
Kohler, G. and C. Milstein. 1976. Derivation of specific antibody producing tissue culture and tumor lines by cell fusion.Eur. J. Immunol.6:511–519.
Korkolainen, M., S. Kontio, J. Korpela, A. Narvanen, P. Partenen, J. Suni, A. Vaheri, and M.-L. Huhtala. 1988. Research on AIDS testing: Synthetic peptide EIA.Lab. Managementpp. 19–21.
Kricka, L.J. 1991. Chemiluminescent and bioluminescent techniques.Clin. Chem.37:1472–1481.
Levine, B.B., A. Ojeda, and B. Benacerraf. 1963. Studies on artificial antigens.III.The genetic control of the immune response at the carrier level.PNAS (USA)71:1574–1577.
Manser, T., L.J. Wysocki, T. Gridley, R.I. Near, and M.L. Gefter. 1985. The molecular evolution of the immune responses.Immunol. Today6:94–101.
Marshall, J.D., W.C. Eveland, and C.W. Smith. 1958. Superiority of fluorescein isothiocyanate (Riggs) for fluorescence antibody technique with a modification of its application.Proc. Soc. Exp. Biol. Med.98:898–900.
Marquez, E., J. Bryant, and M. Pappas. 1989. Enzyme immunoassay for the detection of Lyme borreliosis.J. Clin. Immunoassay12:158–160.
McKinney, R.M. and W.B. Cherry. 1985. Immunofluorescence microscopy. in:Manual of Clinical Microbiology.(Eds., E.H. Lennette, A. Ballows, W.J. Hauser, Jr., et al.) American Society of Microbiology, Washington, DC, pp. 891–897.
Milstein, C. 1980. Monoclonal antibodies.Scient. Am.243:56–64.
Ngo, T.T. and H.M. Lenhoff. 1980. Enzyme modulators as tools for the development of homogeneous enzyme immunoassays.FEBS Lett. 116: 285–288.
Nowinski, R.C., M.R. Tam, L.C. Goldstein, L. Stong, C. Kuo, L. Corey, W.E. Stamm, H.H. Handsfield, J.S. Knapp, and K.K. Holmes. 1983. Monoclonal antibodies for diagnosis of infectious diseases in humans.Science219:637–644.
Pappas, M.G. 1985. Fluorescent microspheres display a wide range of scientific applications.Biomed. Prod.10:23–28.
Pappas, M.G. 1987. New tests may improve Third World health care.Clin. Chem. News13:5.
Pappas, M.G. 1988. Dot immunobinding assay (Dot-ELISA) for rapid clinical serodiagnosis of protozoan and metazoan diseases. in:Handbook of Immunoblotting of Proteins(vol. 2). (Eds., O. Bjerrum and N. Heegaard) CRC Press, Boca Raton, pp. 145–157.
Pappas, M.G. 1988. Dot Enzyme-Linked Immunosorbent Assay (Dot-ELISA). in:Complementary Immunoassays.(Ed., W.P. Collins) Wiley, New York, pp. 113–134.
Pappas, M.G., R. Hajkowski, C.L. Diggs, and W.T. Hockmeyer. 1983. Dot enzyme-linked immunosorbent assay (Dot-ELISA): A micro technique for the rapid diagnosis of visceral leishmaniasis.J. Immunol. Methods64:205–214.
Pappas, M.G., R. Hajkowski, C.L. Diggs, and W.T. Hockmeyer. 1984. Development of an antigen-conservative enzyme immunoassay (Dot-ELISA) for the rapid diagnosis of human leishmaniasis.Trans. Roy. Soc. Trop. Med. Hyg.77:425–426.
Pappas, M.G., R. Hajkowski, C.L. Diggs, and W.T. Hockmeyer. 1985. Disposable nitrocellulose filtration plates simplify the Dot-ELISA for serodiagnosis of visceral leishmaniasis.Ann. Trop. Med. Parasitol.79:147–151.
Pappas, M.G., R. Hajkowski, and W.T. Hockmeyer. 1984. Standardization of the dot-enzyme-linked immunosorbent assay (Dot-ELISA) for human visceral leishmaniasis.Am. J. Trop. Med. Hyg.33:1105–1111.
Pappas, M.G., R. Hajkowski, W.T. Hockmeyer, and C.L. Diggs. 1986. Dipstick serodiagnosis of parasitic diseases using the dot enzyme-linked immunosorbent assay (Dot-ELISA).Fed. Abstr.45:858.
Pappas, M.G., R. Hajkowski, D.B. Tang, and W.T. Hockmeyer. 1985. Reduced false positive reactions in the Dot-ELISA for human visceral leishmaniasis.Clin. Immunol. Immunopathol.34:392–396.
Pritchard, J.A.V., W.H. Sutherland, J.E. Siddall, A.J. Bater, and T.J. Deeley. 1983. Fluorescent probes for the detection of malignant disease. in:Defined Immunofluorescence and Related Cytochemical Methods.(Eds., E.H. Beutner, R.J. Nisengard, and B. Albini) Annals of the New York Academy of Sciences, vol. 420, New York, pp. 219–228.
Rubinstein, K.E., R.S. Schneider, and E.F. Ullmann. 1972. Homogeneous enzyme-immunoassay. A new immunochemical technique.Biochem. Biophys. Res. Commun.47:846–851.
Scott, M.G. 1985. Monoclonal antibodies-Approaching adolescence in diagnostic immunoassays.Trends Biotech.3:7.
Sela, M. 1966. Immunological studies with synthetic polypeptides.Adv. Immunol.5:29–129.
Suresh, M.R., A.C. Cuello, and C. Milstein. 1986. Bispecific monoclonal antibodies from hybridomas.Methods Enzymol. 121: 210–228.
Taylor, R.G. and T.R. Perez. 1978. Serology of amebiasis using the FIAX® system.Arch. Invest. Med. (Mexico)9(Supp1.1):363–366.
Walton, B.C., M.G. Pappas, M. Sierra, Jr., R. Hajkowski, P.R. Jackson, and R. Custodio. 1987. Field use of the Dot-ELISA test for human visceral leishmaniasis in Honduras.Bull. PAHO20:147–156.
Wheatley, M. and R. Langer. 1987. Particles as drug delivery systems.Particul. Sci. Technol.5:53–64.
Wilkinson, M.C., J. Hearn, F.H. Karpowicz, and M. Chainey. 1987. The stability of latex particles in aqueous suspensions.Particul. Sci. Technol.5:65–82.
Yalow, R.S. and S. Berson. 1960. Immunoassay of endogenous insulin in man.J. Clin. Invest.39:11571175.
Yolken, R.H. 1985. Solid phase immunoassays for detection of microbial antigens in body fluids. in:Manual of Clinical Microbiology.(Eds., E.H. Lennette, A. Ballows, W.J. Hauser, Jr., et al.) American Society of Microbiology, Washington, DC, pp. 949–957.
Yolken, R.H., F. Leister, L. Whitcomb, D. Davis, and M.J. Mears. 1983. Enzyme immunoassays for the diagnosis of viral infections. in:Defined Immunofluorescence and Related Cytochemical Methods.(Eds., E.H. Beutner, R.J. Nisengard, and B. Albini) Annals of the New York Academy of Sciences, vol. 420, pp. 381–390.
Book
Biotechnology-Based Diagnostics.by R.F. Taylor and J.S. Schultz. Technomic Pub. Co., Inc., Lancaster, PA, 1991.
Clinical Applications of Monoclonal Antibodies.(Eds., R. Hubbard and V. Marks) Plenum Press, New York, 1988.
Complementary Immunoassays(Ed., W.P. Collins) Wiley, New York, 1988.
Defined Immunofluorescence and Related Cytochemical Methods(Eds., E.H. Beutner, R.J. Nisengard, and B. Albini) Annals of the New York Academy of Sciences, vol. 420, New York, 1983.
Enzyme-Immunoassay(Ed., E.T. Maggio) CRC Press, Boca Raton, 1981.
Immunoassay: A Practical Guide(Eds., D.W. Chan and M.T. Perlstein) Academic Press, Boston, 1987.
Immunoassays: Clinical Techniques for the 1980’s(Eds., R.M. Nakamura, W.R. Dito, and E.S. Tucker) Liss, New York, 1980.
Immunology. by I.M. Roitt, J. Brostoff, and D.K. Male. Gower, New York, 1989.
Microparticle Immunoassay Techniques. by R.J. Galloway. Seradyn, Inc., Indianapolis, IN, 1988.
Microspheres and Drug TherapyPharmaceutical, Immunological and Medical Aspects. (Eds., S.S. Davis, J.G. McVie, and E. Tomlinson) Elsevier, Amsterdam, 1984.
Monoclonal Antibodies for Cancer Detection and Therapy(Eds., R.W. Baldwin and V.S. Byers) Academic Press, New York, 1985.
Monoclonal Antibodies in Cancer(Eds., S. Sell and R. Reisfeld) Humana Press, Clifton, NJ, 1985.
Protein Adsorption(Ed., J.D. Andrade) Plenum Press, New York, 1986.
Synthetic Peptides as Antigens(Eds., R. Porter and J. Whelan) Ciba Foundation Symposium(vol. 119), Wiley, New York, 1986.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pappas, M.G. (1994). Immunodiagnostic Assays. In: The Biotech Business Handbook. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0293-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0293-6_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-7139-7
Online ISBN: 978-1-4612-0293-6
eBook Packages: Springer Book Archive